Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP261131.RAtGdp8D9jmkaU7vC22_VSbN3Daq98NfEBC_uBDMyPoyQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP261131.RAtGdp8D9jmkaU7vC22_VSbN3Daq98NfEBC_uBDMyPoyQ130_assertion type Assertion NP261131.RAtGdp8D9jmkaU7vC22_VSbN3Daq98NfEBC_uBDMyPoyQ130_head.
- NP261131.RAtGdp8D9jmkaU7vC22_VSbN3Daq98NfEBC_uBDMyPoyQ130_assertion description "[The results of this study demonstrate that motesanib inhibited thyroid tumor xenograft growth predominantly through inhibition of angiogenesis and possibly via a direct inhibition of VEGFR2 and Ret expressed on tumor cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261131.RAtGdp8D9jmkaU7vC22_VSbN3Daq98NfEBC_uBDMyPoyQ130_provenance.
- NP261131.RAtGdp8D9jmkaU7vC22_VSbN3Daq98NfEBC_uBDMyPoyQ130_assertion evidence source_evidence_literature NP261131.RAtGdp8D9jmkaU7vC22_VSbN3Daq98NfEBC_uBDMyPoyQ130_provenance.
- NP261131.RAtGdp8D9jmkaU7vC22_VSbN3Daq98NfEBC_uBDMyPoyQ130_assertion SIO_000772 21422803 NP261131.RAtGdp8D9jmkaU7vC22_VSbN3Daq98NfEBC_uBDMyPoyQ130_provenance.
- NP261131.RAtGdp8D9jmkaU7vC22_VSbN3Daq98NfEBC_uBDMyPoyQ130_assertion wasDerivedFrom befree-20140225 NP261131.RAtGdp8D9jmkaU7vC22_VSbN3Daq98NfEBC_uBDMyPoyQ130_provenance.
- NP261131.RAtGdp8D9jmkaU7vC22_VSbN3Daq98NfEBC_uBDMyPoyQ130_assertion wasGeneratedBy ECO_0000203 NP261131.RAtGdp8D9jmkaU7vC22_VSbN3Daq98NfEBC_uBDMyPoyQ130_provenance.